Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Azithromycin can rarely cause a severe drop in white blood cells.

Intermittent isotretinoin can cause various skin, hair, and nail changes.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Sweet syndrome can be the only sign of hairy cell leukemia relapse.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Mouse models help target specific genes in lymphatic cells for research.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

A 5-year-old girl has lipoid proteinosis, causing voice issues, hair thinning, skin lesions, and tongue movement problems.

Tangent screens help detect visual field defects from vigabatrin.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

A Doberman Pinscher had a rare form of autoimmune disease causing hair loss and other severe symptoms.

Low-dose oral minoxidil does not increase pericardial effusions in alopecia patients.

The man was diagnosed with lupus and improved with treatment.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

The nodule was a benign cutaneous lymphadenoma, not cancer, and was successfully removed.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Two patients with lupus had an unusual type of hair loss not typical for the disease.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

All four treatments for early rheumatoid arthritis had similar safety profiles.